It was suggested that the aberrant estrogen signaling in AIS patients was associated with the presence of these polymorphisms affecting both ERα and ERβ and the G-protein coupled estrogen receptor 1 (GPER) [11,12,13,14,15,16,17,18,19,20]. The gene discussed is GPER1; the disease is androgen insensitivity syndrome.